2-aminoimidazole has been researched along with beta-lactams in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melander, C; Peng, L; Su, R; Su, Z; Yeagley, AA | 1 |
| Furlani, RE; Melander, C; Yeagley, AA | 1 |
| Abramovitch, RB; Ackart, DF; Basaraba, RJ; Belardinelli, JM; Blackledge, MS; Jackson, M; Jeon, AB; Johnson, BK; Melander, C; Melander, RJ; Nguyen, TV; Obregón-Henao, A; Podell, BK | 1 |
| Basaraba, RJ; Martin, SE; Melander, C; Nguyen, CM | 1 |
4 other study(ies) available for 2-aminoimidazole and beta-lactams
| Article | Year |
|---|---|
Structural studies on 4,5-disubstituted 2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to β-lactams.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Biofilms; Humans; Imidazoles; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2012 |
A flexible approach to 1,4-di-substituted 2-aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of β-lactams against multi-drug resistant bacteria.
Topics: beta-Lactams; Biofilms; Dose-Response Relationship, Drug; Imidazoles; Methicillin-Resistant Staphylococcus aureus; Molecular Structure; Structure-Activity Relationship | 2013 |
2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.
Topics: Anti-Infective Agents; beta-Lactamases; beta-Lactams; Carbenicillin; Cell Membrane Permeability; Coloring Agents; Imidazoles; Lipids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acids; Penicillin V; Sodium Dodecyl Sulfate; Staining and Labeling; Transcription, Genetic; Vancomycin | 2017 |
Analogue synthesis reveals decoupling of antibiofilm and β-lactam potentiation activities of a lead 2-aminoimidazole adjuvant against Mycobacterium smegmatis.
Topics: Adjuvants, Pharmaceutic; Antitubercular Agents; beta-Lactams; Biofilms; Imidazoles; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis | 2018 |